Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tokai University
With
Scientific Committee for Elucidation of Infantile Asthma
Age
3–3
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Infants born July \~ December 2007 at 33\~35 weeks of gestation
Infants administered at least 3 doses of palivizumab during the first 6 months of life (Palivizumab treated)
Infants not administered any doses of palivizumab during the first 6 months of life (Palivizumab untreated)
You may not be if
Intrauterine growth retardation (less than -2.5SD)
Infants with chronic lung disease (CLD) or other respiratory disease
Infants received mechanical ventilation
Infants with chronic heart disease (CHD) or congenital anomaly (such as immunodeficiency)
Clareo Health | Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants
